Literature DB >> 31591997

Role of Balloon Guide Catheter in Modern Endovascular Thrombectomy.

Ju-Yu Chueh1, Dong-Hun Kang2, Byung Moon Kim3, Matthew J Gounis1.   

Abstract

Proximal flow control achieved with a balloon guide catheter (BGC) during endovascular treatment of acute ischemic stroke is reviewed in this article. In clinical practice, BGCs offer a multi-faceted approach for clot retrieval by creating proximal flow arrest, reducing embolic burden, and shortening procedure time. Evaluation of frontline thrombectomy procedures with BGCs revealed advantages of combined use over the conventional guide catheter (CGC), notably in the significant reduction of distal emboli to both the affected and previously unaffected territories. Recently, new measures of early and complete reperfusion at first thrombectomy pass have been identified as independent predictors of improved outcomes, which were consistently demonstrated with use of BGC as a safe and effective option to minimize number of passes during intervention. Prior randomized controlled trials reported the positive correlation between BGC-treated patients and a lower risk of mortality as well as shortened procedure time. While BGC use is more common in stent retriever-mediated mechanical thrombectomy, preliminary data has shown the potential benefit of device application during contact aspiration thrombectomy to achieve successful recanalization. However, the question of which major endovascular strategy reigns superior as a frontline remains to be answered. Along with clinical case assessments, BGC performance during in-vitro simulation was analyzed to further understand mechanisms for optimization of thrombectomy technique.

Entities:  

Keywords:  Acute stroke; Balloon occlusion; Endovascular thrombectomy; Thrombectomy

Year:  2019        PMID: 31591997     DOI: 10.3340/jkns.2019.0114

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


  7 in total

1.  Balloon guide catheters: use, reject, or randomize?

Authors:  Mayank Goyal; Manon Kappelhof; Johanna M Ospel; Fouzi Bala
Journal:  Neuroradiology       Date:  2021-06-08       Impact factor: 2.804

2.  Safety and feasibility of transradial use of 8F balloon guide catheter Flowgate2 for endovascular thrombectomy in acute ischemic stroke.

Authors:  Mario Martínez-Galdámez; Miguel Schüller; Jorge Galvan; Mercedes de Lera; Vladimir Kalousek; Santiago Ortega-Gutierrez; Juan F Arenillas
Journal:  Interv Neuroradiol       Date:  2021-04-23       Impact factor: 1.610

3.  Clinical and Procedural Outcomes with or without Balloon Guide Catheters during Endovascular Thrombectomy in Acute Ischemic Stroke: A Systematic Review and Meta-analysis with First-line Technique Subgroup Analysis.

Authors:  A Podlasek; P S Dhillon; G Jewett; A Shahein; M Goyal; M Almekhlafi
Journal:  AJNR Am J Neuroradiol       Date:  2021-05-27       Impact factor: 4.966

4.  Comparing the Conventional and Balloon-Guided Catheter-Assisted SWIM Technology for the Treatment of Acute Ischemic Stroke.

Authors:  Zhengwen Chen; Yizhi Liu; Bo Li; Chen Yuan; Kaiwen Hou; Long Chen; Peicheng Li
Journal:  Front Neurol       Date:  2022-07-13       Impact factor: 4.086

5.  Efficacy of Balloon Guide Catheter-Assisted Thrombus Repair in Stroke Treatment: A Retrospective Survey in China.

Authors:  Qiang Li; Tengfei Zhou; Yingkun He; Min Guan; Zhaoshuo Li; Liheng Wu; Changming Wen; Haibo Wang; Guang Feng; Ziliang Wang; Liangfu Zhu; Tianxiao Li
Journal:  Biomed Res Int       Date:  2022-09-28       Impact factor: 3.246

6.  Can Transradial Mechanical Thrombectomy Be an Alternative in Case of Impossible Transfemoral Approach for Mechanical Thrombectomy? A Single Center's Experience.

Authors:  Hyun Wook Cho; Hyo Sub Jun
Journal:  J Korean Neurosurg Soc       Date:  2020-11-20

7.  Maximizing the catheter-to-vessel size optimizes distal flow control resulting in improved revascularization in vitro for aspiration thrombectomy.

Authors:  Raul G Nogueira; David Ryan; Liam Mullins; John Thornton; Seán Fitzgerald
Journal:  J Neurointerv Surg       Date:  2021-03-15       Impact factor: 5.836

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.